Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

6WYS

Lon protease proteolytic domain

6WYS の概要
エントリーDOI10.2210/pdb6wys/pdb
分子名称Lon protease homolog, mitochondrial, SULFATE ION (3 entities in total)
機能のキーワードproteolytic domain, hydrolase
由来する生物種Homo sapiens (Human)
タンパク質・核酸の鎖数3
化学式量合計71844.98
構造登録者
Lee, C.C.,Spraggon, G. (登録日: 2020-05-13, 公開日: 2021-04-14, 最終更新日: 2023-10-18)
主引用文献Kingsley, L.J.,He, X.,McNeill, M.,Nelson, J.,Nikulin, V.,Ma, Z.,Lu, W.,Zhou, V.W.,Manuia, M.,Kreusch, A.,Gao, M.Y.,Witmer, D.,Vaillancourt, M.T.,Lu, M.,Greenblatt, S.,Lee, C.,Vashisht, A.,Bender, S.,Spraggon, G.,Michellys, P.Y.,Jia, Y.,Haling, J.R.,Lelais, G.
Structure-Based Design of Selective LONP1 Inhibitors for Probing In Vitro Biology.
J.Med.Chem., 64:4857-4869, 2021
Cited by
PubMed Abstract: LONP1 is an AAA+ protease that maintains mitochondrial homeostasis by removing damaged or misfolded proteins. Elevated activity and expression of LONP1 promotes cancer cell proliferation and resistance to apoptosis-inducing reagents. Despite the importance of LONP1 in human biology and disease, very few LONP1 inhibitors have been described in the literature. Herein, we report the development of selective boronic acid-based LONP1 inhibitors using structure-based drug design as well as the first structures of human LONP1 bound to various inhibitors. Our efforts led to several nanomolar LONP1 inhibitors with little to no activity against the 20S proteasome that serve as tool compounds to investigate LONP1 biology.
PubMed: 33821636
DOI: 10.1021/acs.jmedchem.0c02152
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (2.229 Å)
構造検証レポート
Validation report summary of 6wys
検証レポート(詳細版)ダウンロードをダウンロード

252456

件を2026-04-22に公開中

PDB statisticsPDBj update infoContact PDBjnumon